First Edition: April 13, 2018
Today's early morning highlights from the major news organizations.
The independent source for health policy research, polling, and news.
29,241 - 29,260 of 112,177 Results
Today's early morning highlights from the major news organizations.
Editorial pages focus on these and other health topics.
Each week, KHN's Shefali Luthra finds interesting reads from around the Web.
Media outlets report on news from Texas, Colorado, Georgia, Arizona, Ohio, Maryland, Tennessee, Missouri, Illinois and New York.
"Rampage" is the latest movie to feature CRISPR as a plot device. Stat takes a look at what it gets right and wrong. In other public health news: exercise, OB-GYNs, heart valves and memory loss.
A new study finds that the risk appears to dissipate after one month. But experts say they're not willing to change guidelines just quite yet.
It's unclear exactly why night owls are more likely to die than the early risers in this time period, and the study didn't offer explanations. "We think the problem is really when the night owl tries to live in a morning-lark world," said lead author Kristen Knutson.
The dilation and evacuation procedure was used in 537 of 3,312 abortions done in Kentucky in 2016. For women in their second trimester who are covered by the ban, the result is severe — "extinguished access" to abortion in Kentucky, the suit said.
"Every week, we count the doses we have left and make hard decisions about who will receive the medication and who will have to go without," said Baltimore Health Commissioner Dr. Leana Wen. In other news on the crisis: more Americans are seeing the epidemic as a significant issue; lawmakers want to pass legislation to curb crisis soon; a look at the effects of stopping long-term use; and more.
This time, Johnson & Johnson was ordered to pay $80 million in damages on charges the company hid that its products were tainted by asbestos.
Stat offers the juciest -- and strangest -- tidbits from reporter John Carreyrou's new book on the once-promising blood-testing startup.
The state lawmakers returned to Richmond for a special session to iron out problems with the budget, which had been stymied by what to do with the state's Medicaid program.
A new paper finds that some drugs approved under a special law to bring "breakthrough" treatments to market faster are not actually significant scientific advances. In other pharmaceutical news: Sen. Cory Booker (D-N.J.) lashes out at drugmakers for using tax windfalls to help shareholders; insurers are starting to pass rebates directly on to consumers; and the SEC and the FDA both launch investigations into two different clinical trials.
NIH Director Francis Collins assured the lawmakers he was "aggressively" investigating the ethical concerns over scientists' reported attempts to woo the industry into funding a study that touts the benefits of moderate drinking.
The health law has gone through many changes in the past year or so; Modern Healthcare offers a look at the current state of affairs.
House Speaker Paul Ryan (R-Wis.) is leaving behind a mixed legacy on health care, and giving up on some of his dreams to reform entitlement programs like Medicare.
Today's early morning highlights from the major news organizations.
Editorial pages focus on these and other health topics.
Read recent commentaries about drug-cost issues.
News outlets report on stories related to pharmaceutical pricing.
© 2026 KFF